Skip to main content
24 February 2021
Last updated:
Wednesday 24 February 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Wendy Levin joins Biofidelity as chief medical officer

Wednesday 10 February 2021
Company
Biofidelity Ltd
Appointee Name
Wendy 
Levin
Country

United Kingdom

The British cancer diagnostics company, Biofidelity Ltd, has named Wendy Levin as chief medical officer, based in the US. The appointment is part of an expansion of the company’s executive team following a recent Series A financing. Dr Levin is an oncologist and haematologist with over 15 years of experience in biotech. She began her undergraduate and graduate career at the University of California, Los Angeles, US, where she co-authored the first publications on HER-2/neu in breast and ovarian cancers.

Biofidelity announced the appointment on 28 January 2021

Copyright 2021 Evernow Publishing Ltd.

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.